Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 117784607 | 11778460 | 7 | F | 20131224 | 20160708 | 20151125 | 20160721 | EXP | CA-VALIDUS PHARMACEUTICALS LLC-CA-2015VAL000516 | VALIDUS | 0.00 | Y | 0.00000 | 20160721 | CN | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 117784607 | 11778460 | 1 | PS | METOPROLOL TARTRATE. | METOPROLOL TARTRATE | 1 | UNK | U | 17963 | ||||||||||
| 117784607 | 11778460 | 2 | SS | SANDOSTATIN | OCTREOTIDE ACETATE | 1 | Intramuscular | 30 MG, QMO (SANDOSTATIN LAR) | 0 | 30 | MG | ||||||||
| 117784607 | 11778460 | 3 | SS | SANDOSTATIN | OCTREOTIDE ACETATE | 1 | Intramuscular | 30 MG, BIW (EVERY 2 WEEKS) | 0 | 30 | MG | ||||||||
| 117784607 | 11778460 | 4 | SS | SANDOSTATIN | OCTREOTIDE ACETATE | 1 | Subcutaneous | TEST DOSE ONCE/SINGLE | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 117784607 | 11778460 | 1 | Product used for unknown indication |
| 117784607 | 11778460 | 2 | Pancreatic neuroendocrine tumour metastatic |
| 117784607 | 11778460 | 4 | Pancreatic neuroendocrine tumour metastatic |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 117784607 | 11778460 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 117784607 | 11778460 | Blood glucose decreased | |
| 117784607 | 11778460 | Blood glucose increased | |
| 117784607 | 11778460 | Blood pressure systolic increased | |
| 117784607 | 11778460 | Cough | |
| 117784607 | 11778460 | Extrasystoles | |
| 117784607 | 11778460 | Glycosylated haemoglobin increased | |
| 117784607 | 11778460 | Hepatic lesion | |
| 117784607 | 11778460 | Hypertension | |
| 117784607 | 11778460 | Inappropriate schedule of drug administration | |
| 117784607 | 11778460 | Injection site mass | |
| 117784607 | 11778460 | Injection site pain | |
| 117784607 | 11778460 | Malaise | |
| 117784607 | 11778460 | Malignant neoplasm progression | |
| 117784607 | 11778460 | Metastases to liver | |
| 117784607 | 11778460 | Nasopharyngitis | |
| 117784607 | 11778460 | Neoplasm | |
| 117784607 | 11778460 | Peritoneal disorder | |
| 117784607 | 11778460 | Rhinorrhoea |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 117784607 | 11778460 | 2 | 20131224 | 0 | ||
| 117784607 | 11778460 | 4 | 20131206 | 20131206 | 0 |